WASF2, WASP family member 2, 10163

N. diseases: 95; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.060 Biomarker group BEFREE Among Wave 1 very-high-risk drinkers, lower odds of depression and/or anxiety disorders at Wave 2 were predicted by reductions in WHO risk levels of one-, two- or three-levels (aOR = 0.42, 0.37, 0.67, p-values 0.04-<.0001), as was the persistence of depression and/or anxiety disorders among those with such disorders at Wave 1 (aOR = 0.37, 0.29, 0.51, p-values .03-<.0001). 30852375 2019
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.060 AlteredExpression group BEFREE The goals of the two studies were to: (i) explore the concurrent associations between self-reported anxiety symptoms and diurnal variations of sIgA across the day using repeated daily samples of sIgA; and (ii) examine transactional relations between children's anxiety and aggregated total amount of sIgA levels across successive periods from middle childhood (Wave 1; ages 9-12) to early adolescence (Wave 2; ages 12-15), and from early to mid- adolescence (Wave 3; ages 15-18). 29171012 2018
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.060 Biomarker group BEFREE Anxiety and depressive symptoms were measured at Wave 1 (immediately after bereavement), social support was measured at Wave 2 (18 months after bereavement), and anxiety and depressive symptoms were also measured at Wave 3 (48 months after bereavement). 28103522 2017
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.060 GeneticVariation group BEFREE Those with any Wave 1 disorder were at increased risk of incident mood (RR range = 1.2-2.1) and anxiety (RR = 1.5-2.7) disorders at Wave 2. 28531836 2017
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.060 GeneticVariation group BEFREE Conversely, Wave 1 major depressive episodes significantly increased risk of Wave 2 manic episodes (AOR: 2.2; 1.7-2.9) and anxiety disorders (AOR: 1.7; 1.5-2.0), although not substance use disorders (AOR: 1.0; 0.9-1.2). 27137742 2017
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.060 Biomarker group BEFREE After a three year interval, the presence of anxiety disorders was determined at Wave II. 23953022 2013